Remove 2011 Remove Family Remove Individual Remove IT
article thumbnail

National variation in ASCVD risk between Pooled Cohort Equations and PREVENT [Cardiovascular disease]

Annals of Family Medicine

Context In November 2023, the American Heart Association (AHA) released PREVENT, a new set of risk equations to calculate an individual's risk of atherosclerotic cardiovascular disease (ASCVD). Each individual was separated into clinically significant risk categories of <7.5%, 7.5-10%, Results 3,885 individuals met the criteria.

article thumbnail

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

Design and analysis: The study employed a comprehensive cohort design to compare individuals with T2D who were Ethiopian-born to their Israeli-born counterparts. Population: Jewish CHS members, aged 18+, diagnosed with T2D between 2000-2011, born in Israel or Ethiopia. Intervention: 10-year follow-up to track T2D outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Importance of Community Resources for Breastfeeding [Child and adolescent health]

Annals of Family Medicine

SAFE used a stratified, two-stage, clustered design to obtain a nationally representative sample of mothers of infants; mothers were enrolled from 32 US birth hospitals, January 2011-March 2014. Looking beyond the individual and supporting healthy communities will be critical to improve US breastfeeding rates.

Community 130
article thumbnail

Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky

GeriPal

Summary Transcript Summary. We’ve talked at length on prior podcasts about the failures of aducnumab, Biogen, and the FDA’s decision to approve it. . But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No No it’s not just the French version of Aducanumab). . In an article in the NEJM (a published article this time, wonder of wonders!)

IT 105
article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

Summary Transcript CME Summary Many older adults lose decision-making capacity during serious illnesses, and a significant percentage lack family or friends to assist with decisions. How should we care for unrepresented individuals in inpatient and outpatient settings? Why not use the older term unbefriended? Can you guys do that one?

article thumbnail

Storycatching: Podcast with Heather Coats and Thor Ringler

GeriPal

Our loves, our triumphs, our failures, our work, our families. . Eric’s blog post on Dignity Therapy from 2011. Summary Transcript Summary. Eric and I weren’t sure what to call this podcast – storytelling and medicine? Narrative medicine? It wasn’t until the end that the best term emerged – storycatching. Wonderful work.

article thumbnail

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

2011-2014 JAMDA 2020 Efficacy of Gabapentinoids: Gabapentinoids for Pain: Potential Unintended Consequences. By 2015 that number increased to 4% of US adults. There are a lot of reasons that may explain the massive increase in use of these drugs. One thing is clear, it is not because people are using it for FDA approved indications.